CD44 and neoplasm: Because CD44 was described as a marker of GBM CSCs, also known as glioma stem–progenitor cells or glioma-initiating cells (7), we also annotated the stem-like cells besides the six GBM tumor cellular states in malignant cells (Figure 9F).